The Global Tablet Press Machines Market was valued at USD 1.52 billion in 2025 and is estimated to grow at a CAGR of 5.3% to reach USD 2.56 billion by 2035.
Market expansion is driven by the continuous growth of the pharmaceutical sector and the rising production of oral solid dosage drugs. Tablets remain one of the most widely used drug delivery formats due to their affordability, ease of administration, and extended shelf life. Increasing global prevalence of chronic diseases is further pushing pharmaceutical companies to scale up tablet production, thereby increasing demand for high-capacity and high-performance compression equipment. In addition, the expansion of generic drug manufacturing is contributing significantly to equipment adoption, particularly in emerging economies focused on delivering cost-effective medicines to large patient populations. Contract manufacturing organizations are also strengthening demand by investing in flexible and multi-functional tablet compression systems capable of handling varied formulations and batch sizes. This shift is reinforcing the need for advanced machinery that ensures consistent output quality while supporting large-scale production requirements across the pharmaceutical value chain.
The multiple station machines segment generated USD 1.08 billion in 2025. This category, commonly known as rotary tablet presses, remains the preferred choice for high-volume production environments. These machines operate using a rotating turret equipped with multiple tooling stations that allow simultaneous tablet compression during each cycle. This design significantly enhances production efficiency compared to single-station systems, making them ideal for large-scale pharmaceutical and nutraceutical manufacturing operations where high throughput is essential.
The fully-automatic segment accounted for 48% share in 2025. This segment continues to expand due to its ability to automate the entire tablet production process with minimal human intervention. Functions such as powder feeding, compression, weight adjustment, and tablet ejection are fully synchronized, ensuring consistent product quality and improved operational efficiency. Such systems are widely adopted in pharmaceutical and nutraceutical production environments where precision, regulatory compliance, and large-scale output are critical requirements.
U.S. Tablet Press Machines Market held a 75.8% share, generating USD 0.36 billion in 2025. Market growth in the country is supported by strong pharmaceutical demand, a well-established healthcare infrastructure, and advanced manufacturing capabilities. Production is largely focused on high-quality oral solid dosage forms used in the treatment of chronic and long-term conditions. In addition, strict regulatory standards enforced by the FDA are encouraging manufacturers to invest in advanced tablet compression technologies that ensure compliance, precision, and product consistency across production cycles.
Major players operating in the Global Tablet Press Machines Industry include Fette Compacting, IMA Active, GEA Group, Korsch AG, Romaco, ACG Pharma Technologies, Manesty (Bosch/Syntegon), Sejong Pharmatech, Cadmach Machinery, Elizabeth Hata, Stokes, Shanghai Tianhe, Riddhi Pharma, Riva S.A., Glatt, PTK-GB, Fluid Pack, Karnavati/Rimek, Prism Pharma, Chamunda Pharma, and Compression Components & Service. Companies in the tablet press machines market are focusing on advancing automation and precision engineering to improve production efficiency and product consistency. Manufacturers are integrating digital monitoring systems, real-time process control, and predictive maintenance capabilities to reduce downtime and enhance operational reliability. Expansion of modular machine designs is enabling flexible production setups that accommodate different tablet sizes and formulations. Firms are also investing in high-speed rotary systems to meet growing demand for large-scale pharmaceutical manufacturing. Strategic partnerships with pharmaceutical companies and contract manufacturers are strengthening market penetration. Additionally, emphasis on regulatory compliance, energy-efficient systems, and reduced material wastage is helping companies improve competitiveness.
This product will be delivered within 2-4 business days.
Market expansion is driven by the continuous growth of the pharmaceutical sector and the rising production of oral solid dosage drugs. Tablets remain one of the most widely used drug delivery formats due to their affordability, ease of administration, and extended shelf life. Increasing global prevalence of chronic diseases is further pushing pharmaceutical companies to scale up tablet production, thereby increasing demand for high-capacity and high-performance compression equipment. In addition, the expansion of generic drug manufacturing is contributing significantly to equipment adoption, particularly in emerging economies focused on delivering cost-effective medicines to large patient populations. Contract manufacturing organizations are also strengthening demand by investing in flexible and multi-functional tablet compression systems capable of handling varied formulations and batch sizes. This shift is reinforcing the need for advanced machinery that ensures consistent output quality while supporting large-scale production requirements across the pharmaceutical value chain.
The multiple station machines segment generated USD 1.08 billion in 2025. This category, commonly known as rotary tablet presses, remains the preferred choice for high-volume production environments. These machines operate using a rotating turret equipped with multiple tooling stations that allow simultaneous tablet compression during each cycle. This design significantly enhances production efficiency compared to single-station systems, making them ideal for large-scale pharmaceutical and nutraceutical manufacturing operations where high throughput is essential.
The fully-automatic segment accounted for 48% share in 2025. This segment continues to expand due to its ability to automate the entire tablet production process with minimal human intervention. Functions such as powder feeding, compression, weight adjustment, and tablet ejection are fully synchronized, ensuring consistent product quality and improved operational efficiency. Such systems are widely adopted in pharmaceutical and nutraceutical production environments where precision, regulatory compliance, and large-scale output are critical requirements.
U.S. Tablet Press Machines Market held a 75.8% share, generating USD 0.36 billion in 2025. Market growth in the country is supported by strong pharmaceutical demand, a well-established healthcare infrastructure, and advanced manufacturing capabilities. Production is largely focused on high-quality oral solid dosage forms used in the treatment of chronic and long-term conditions. In addition, strict regulatory standards enforced by the FDA are encouraging manufacturers to invest in advanced tablet compression technologies that ensure compliance, precision, and product consistency across production cycles.
Major players operating in the Global Tablet Press Machines Industry include Fette Compacting, IMA Active, GEA Group, Korsch AG, Romaco, ACG Pharma Technologies, Manesty (Bosch/Syntegon), Sejong Pharmatech, Cadmach Machinery, Elizabeth Hata, Stokes, Shanghai Tianhe, Riddhi Pharma, Riva S.A., Glatt, PTK-GB, Fluid Pack, Karnavati/Rimek, Prism Pharma, Chamunda Pharma, and Compression Components & Service. Companies in the tablet press machines market are focusing on advancing automation and precision engineering to improve production efficiency and product consistency. Manufacturers are integrating digital monitoring systems, real-time process control, and predictive maintenance capabilities to reduce downtime and enhance operational reliability. Expansion of modular machine designs is enabling flexible production setups that accommodate different tablet sizes and formulations. Firms are also investing in high-speed rotary systems to meet growing demand for large-scale pharmaceutical manufacturing. Strategic partnerships with pharmaceutical companies and contract manufacturers are strengthening market penetration. Additionally, emphasis on regulatory compliance, energy-efficient systems, and reduced material wastage is helping companies improve competitiveness.
Comprehensive Market Analysis and Forecast
- Industry trends, key growth drivers, challenges, future opportunities, and regulatory landscape
- Competitive landscape with Porter’s Five Forces and PESTEL analysis
- Market size, segmentation, and regional forecasts
- In-depth company profiles, business strategies, financial insights, and SWOT analysis
This product will be delivered within 2-4 business days.
Table of Contents
Chapter 1 Methodology and Scope
Chapter 2 Executive Summary
Chapter 3 Industry Insights
Chapter 4 Competitive Landscape, 2025
Chapter 5 Market Estimates and Forecast, by Machine Type, 2022-2035 (USD Billion)
Chapter 6 Market Estimates and Forecast, by Mode of Operation, 2022-2035 (USD Billion)
Chapter 7 Market Estimates and Forecast, by Production Capacity, 2022-2035 (USD Billion)
Chapter 8 Market Estimates and Forecast, by End Use Industry, 2022-2035 (USD Billion)
Chapter 9 Market Estimates and Forecast, by Distribution Channel, 2022-2035 (USD Billion)
Chapter 10 Market Estimates and Forecast, by Region, 2022-2035 (USD Billion)
Chapter 11 Company Profiles
Companies Mentioned
The companies profiled in this Tablet Press Machines market report include:- RTX Corporation
- Lockheed Martin
- Northrop Grumman
- Thales Group
- Leonardo S.p.A.
- L3Harris Technologies
- Anduril Industries
- BAE Systems
- Rheinmetall AG
- Israel Aerospace Industries
- Elbit Systems
- DroneShield
- Dedrone
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 220 |
| Published | May 2026 |
| Forecast Period | 2025 - 2035 |
| Estimated Market Value ( USD | $ 1.52 Billion |
| Forecasted Market Value ( USD | $ 2.56 Billion |
| Compound Annual Growth Rate | 5.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 14 |
